Viral G protein-coupled receptor up-regulates Angiopoietin-like 4 promoting angiogenesis and vascular permeability in Kaposi's sarcoma

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 32, 2010, Pages 14363-14368

  Ma, Tao ^a   Jham, Bruno C ^a   Hu, Jiadi ^a   Friedman, Eitan R ^a   Basile, John R ^a   Molinolo, Alfredo ^b   Sodhi, Akrit ^c   Montaner, Silvia ^a  

^a UNIVERSITY OF MARYLAND   (United States)

^b NATIONAL INSTITUTE OF DENTAL AND CRANIOFACIAL RESEARCH   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Endothelial cell; Human herpesvirus 8; Kaposi's sarcoma associated herpesvirus; Rho GTPase

Indexed keywords

ANGIOPOIETIN; G PROTEIN COUPLED RECEPTOR; PROTEIN ANGIOPOIETIN LIKE 4; RHO KINASE; UNCLASSIFIED DRUG; VASCULOTROPIN; ANGPTL4 PROTEIN, HUMAN; CHEMOKINE RECEPTOR; G PROTEIN COUPLED RECEPTOR, HUMAN HERPESVIRUS 8; G PROTEIN-COUPLED RECEPTOR, HUMAN HERPESVIRUS 8; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; BLOOD VESSEL PERMEABILITY; CARCINOGENESIS; HUMAN; KAPOSI SARCOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; TUMOR VASCULARIZATION; UPREGULATION; BIOSYNTHESIS; CAPILLARY PERMEABILITY; CELL LINE; GENETICS; HOST PATHOGEN INTERACTION; NEOVASCULARIZATION (PATHOLOGY); PARACRINE SIGNALING; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGIOPOIETINS; CAPILLARY PERMEABILITY; CELL LINE; HOST-PATHOGEN INTERACTIONS; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; PARACRINE COMMUNICATION; RECEPTORS, CHEMOKINE; SARCOMA, KAPOSI; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

ANIMALIA; HUMAN HERPESVIRUS 8;

EID: 77956272177     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1001065107     Document Type: Article

References (38)

1. Moore PS, Chang Y (1998) Kaposi's sarcoma-associated herpesvirus-encoded oncogenes and oncogenesis. J Natl Cancer Inst Monogr 23:65-71.
2. Chang Y, et al. (1994) Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266:1865-1869.
3. Moore PS, Chang Y (2001) Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 356:499-516.
4. Dourmishev LA, Dourmishev AL, Palmeri D, Schwartz RA, Lukac DM (2003) Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 67:175-212.
5. Cesarman E (2002) The role of Kaposi's sarcoma-associated herpesvirus (KSHV/HHV-8) in lymphoproliferative diseases. Recent Results Cancer Res 159:27-37.
6. Krown SE, Lee JY, Dittmer DP, AIDS Malignancy Consortium (2008) More on HIV-associated Kaposi's sarcoma. N Engl J Med 358:535-536, author reply 536.
7. Ganem D (1998) Human herpesvirus 8 and its role in the genesis of Kaposi's sarcoma. Curr Clin Top Infect Dis 18:237-251.
8. Jham BC, Montaner S (2010) The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor: Lessons on dysregulated angiogenesis from a viral oncogene. J Cell Biochem 110:1-9.
9. Cornali E, et al. (1996) Vascular endothelial growth factor regulates angiogenesis and vascular permeability in Kaposi's sarcoma. Am J Pathol 149:1851-1869.
10. Masood R, et al. (1997) Vascular endothelial growth factor/vascular permeability factor is an autocrine growth factor for AIDS-Kaposi sarcoma. Proc Natl Acad Sci USA 94:979-984.
11. Nakamura S, Murakami-Mori K, Rao N, Weich HA, Rajeev B (1997) Vascular endothelial growth factor is a potent angiogenic factor in AIDS-associated Kaposi's sarcoma-derived spindle cells. J Immunol 158:4992-5001.
12. Weindel K, Marmé D, Weich HA (1992) AIDS-associated Kaposi's sarcoma cells in culture express vascular endothelial growth factor. Biochem Biophys Res Commun 183:1167-1174.
13. Sodhi A, Montaner S, Gutkind JS (2004) Viral hijacking of G-protein-coupled-receptor signalling networks. Nat Rev Mol Cell Biol 5:998-1012.
14. Sodhi A, et al. (2000) The Kaposi's sarcoma-associated herpes virus G protein-coupled receptor up-regulates vascular endothelial growth factor expression and secretion through mitogen-activated protein kinase and p38 pathways acting on hypoxia-inducible factor 1alpha. Cancer Res 60:4873-4880.
15. Bais C, et al. (2003) Kaposi's sarcoma associated herpesvirus G protein-coupled receptor immortalizes human endothelial cells by activation of the VEGF receptor-2/ KDR. Cancer Cell 3:131-143.
16. Montaner S, et al. (2003) Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell 3:23-36.
17. Bais C, et al. (1998) G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391:86-89.
18. Jensen KK, et al. (2005) The human herpes virus 8-encoded chemokine receptor is required for angioproliferation in a murine model of Kaposi's sarcoma. J Immunol 174:3686-3694.
19. Hato T, Tabata M, Oike Y (2008) The role of Angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med 18:6-14.
20. Montaner S, et al. (2006) The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor as a therapeutic target for the treatment of Kaposi's sarcoma. Cancer Res 66:168-174. (Pubitemid 43166022)
21. Le Jan S, et al. (2003) Angiopoietin-like 4 is a proangiogenic factor produced during ischemia and in conventional renal cell carcinoma. Am J Pathol 162:1521-1528.
22. Hermann LM, et al. (2005) Angiopoietin-like-4 is a potential angiogenic mediator in arthritis. Clin Immunol 115:93-101.
23. Ito Y, et al. (2003) Inhibition of angiogenesis and vascular leakiness by angiopoietin-related protein 4. Cancer Res 63:6651-6657.
24. Cazes A, et al. (2006) Extracellular matrix-bound Angiopoietin-like 4 inhibits endothelial cell adhesion, migration, and sprouting and alters actin cytoskeleton. Circ Res 99:1207-1215.
25. Yang YH, et al. (2008) Suppression of the Raf/MEK/ERK signaling cascade and inhibition of angiogenesis by the carboxyl terminus of Angiopoietin-like protein 4. Arterioscler Thromb Vasc Biol 28:835-840.
26. Chomel C, et al. (2009) Interaction of the coiled-coil domain with glycosaminoglycans protects Angiopoietin-like 4 from proteolysis and regulates its antiangiogenic activity. FASEB J 23:940-949.
27. Guedez L, et al. (2003) Quantitative assessment of angiogenic responses by the directed in vivo angiogenesis assay. Am J Pathol 162:1431-1439.
28. Padua D, et al. (2008) TGFbeta primes breast tumors for lung metastasis seeding through Angiopoietin-like 4. Cell 133:66-77.
29. Galaup A, et al. (2006) Angiopoietin-like 4 prevents metastasis through inhibition of vascular permeability and tumor cell motility and invasiveness. Proc Natl Acad Sci USA 103:18721-18726.
30. Bryan BA, D'Amore PA (2007) What tangled webs they weave: Rho-GTPase control of angiogenesis. Cell Mol Life Sci 64:2053-2065.
31. Dejana E, Tournier-Lasserve E, Weinstein BM (2009) The control of vascular integrity by endothelial cell junctions:Molecular basis and pathological implications. Dev Cell 16:209-221.
32. Yang TY, et al. (2000) Transgenic expression of the chemokine receptor encoded by human herpesvirus 8 induces an angioproliferative disease resembling Kaposi's sarcoma. J Exp Med 191:445-454.
33. Guo HG, et al. (2003) Kaposi's sarcoma-like tumors in a human herpesvirus 8 ORF74 transgenic mouse. J Virol 77:2631-2639.
34. Dezube BJ, Sullivan R, Koon HB (2006) Emerging targets and novel strategies in the treatment of AIDS-related Kaposi's sarcoma: Bidirectional translational science. J Cell Physiol 209:659-662.
35. Gealekman O, et al. (2008) Enhanced angiogenesis in obesity and in response to PPARgamma activators through adipocyte VEGF and ANGPTL4 production. Am J Physiol Endocrinol Metab 295:E1056-E1064.
36. Gasparini G, Longo R, Toi M, Ferrara N (2005) Angiogenic inhibitors: A new therapeutic strategy in oncology. Nat Clin Pract Oncol 2:562-577.
37. Lal A, et al. (2001) Transcriptional response to hypoxia in human tumors. J Natl Cancer Inst 93:1337-1343.
38. Montaner S, Sodhi A, Pece S, Mesri EA, Gutkind JS (2001) The Kaposi's sarcoma-associated herpesvirus G protein-coupled receptor promotes endothelial cell survival through the activation of Akt/protein kinase B. Cancer Res 61:2641-2648.